421 related articles for article (PubMed ID: 23440791)
1. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
[TBL] [Abstract][Full Text] [Related]
2. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
[TBL] [Abstract][Full Text] [Related]
3. Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005642. PubMed ID: 24585451
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012143. PubMed ID: 28585310
[TBL] [Abstract][Full Text] [Related]
5. Nitazoxanide for chronic hepatitis C.
Nikolova K; Gluud C; Grevstad B; Jakobsen JC
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
[TBL] [Abstract][Full Text] [Related]
6. Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.
Gurusamy KS; Tsochatzis E; Toon CD; Davidson BR; Burroughs AK
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006573. PubMed ID: 24297303
[TBL] [Abstract][Full Text] [Related]
7. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.
Gurusamy KS; Tsochatzis E; Toon CD; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006803. PubMed ID: 24307460
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.
Gluud LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2007 Jul; 2002(2):CD002234. PubMed ID: 17636700
[TBL] [Abstract][Full Text] [Related]
9. Nutritional support for liver disease.
Koretz RL; Avenell A; Lipman TO
Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticosteroids for viral hepatitis C.
Brok J; Mellerup MT; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2004; 2004(2):CD002904. PubMed ID: 15106184
[TBL] [Abstract][Full Text] [Related]
11. Antibody induction versus corticosteroid induction for liver transplant recipients.
Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010252. PubMed ID: 24880007
[TBL] [Abstract][Full Text] [Related]
12. Bile acids for viral hepatitis.
Chen W; Liu J; Gluud C
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003181. PubMed ID: 17943781
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline for alcoholic hepatitis.
Whitfield K; Rambaldi A; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007339. PubMed ID: 19821406
[TBL] [Abstract][Full Text] [Related]
14. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
Rambaldi A; Jacobs BP; Gluud C
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003620. PubMed ID: 17943794
[TBL] [Abstract][Full Text] [Related]
15. Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Bell MC; Robuck PR; Wright EC; Mihova MS; Hofmann C; De Santo JL; Milstein SL; Richtmyer PA; Shelton JL; Cormier M; King DL; Park CJ; Molchen WA; Park Y; Kelley M
Clin Trials; 2009 Dec; 6(6):618-27. PubMed ID: 19889888
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccination for patients with chronic renal failure.
Schroth RJ; Hitchon CA; Uhanova J; Noreddin A; Taback SP; Moffatt ME; Zacharias JM
Cochrane Database Syst Rev; 2004; 2004(3):CD003775. PubMed ID: 15266500
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil for alcoholic liver disease.
Fede G; Germani G; Gluud C; Gurusamy KS; Burroughs AK
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002800. PubMed ID: 21678335
[TBL] [Abstract][Full Text] [Related]
18. Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
Wei F; Liu J; Liu F; Hu H; Ren H; Hu P
PLoS One; 2014; 9(4):e90611. PubMed ID: 24699257
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.
Pavlov CS; Casazza G; Semenistaia M; Nikolova D; Tsochatzis E; Liusina E; Ivashkin VT; Gluud C
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011602. PubMed ID: 26934429
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of seven interventions for chronic hepatitis D: a systematic review and network meta-analysis of randomized controlled trials.
Rong Y; Ju X; Sun P; Wang Y
BMC Infect Dis; 2023 Oct; 23(1):726. PubMed ID: 37880598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
